Citations 2

Plain language summary of PAPILLON: amivantamab plus chemotherapy in untreated EGFR -mutated non-small-cell lung cancer

Future Oncology | July 16, 2024 | Volume: 20 | Issue: 32 | Pages: 2409-2421

10.1080/14796694.2024.2371698 | PMID 39012623

TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors

Future Oncology | May 17, 2024 | Volume: 19 | Issue: 2 | Pages: 123-135

10.2217/fon-2022-1059 | PMID 36877099